# ISO/TR 12417-2:2017 — Withdrawn and superseded ISO standards For ISO/TR 12417-2:2017, item title is Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information; status code is 9599; successor is ISO/TR 12417-2:2022; withdrawn / published date is 2017-11-21, recorded from its source on 2026-08-05. - **Identifier:** ISO/TR 12417-2:2017 _(verified: appears in the quote below)_ - **Item title:** Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information _(verified: appears in the quote below)_ - **Status code:** 9599 _(verified: appears in the quote below)_ - **Successor:** ISO/TR 12417-2:2022 - **Withdrawn / published date:** 2017-11-21 _(verified: appears in the quote below)_ ## What the source says > 63851,TR,,ISO/TR 12417-2:2017,Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information,Implants cardiovasculaires et circuits extra-corporels — Produits de combinaison médicament-dispositif vasculaire — Partie 2: Directives règlementaires locales,2017-11-21,1,['11.040.40'],ISO/TC 150/SC 2,9599,,[80895],['en'],29,"
ISO/TR 12417-2:2017 provides region-specific information for
- local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;
- changes related to the drug containing part and how they are evaluated by the different ## Source - https://isopublicstorageprod.blob.core.windows.net/opendata/_latest/iso_deliverables_metadata/csv/iso_deliverables_metadata.csv Last verified: 2026-08-05. Review by: 2027-02-01. Part of [Withdrawn and superseded ISO standards](https://referencesource.org/iso-standard-supersessions/).